Prevention of COVID-19 in patients with IBD

Affiliations

¹ Department of Gastroenterology, St Mary's Hospital, London W2 1NY, UK. Electronic address: Jonathansegal1@nhs.net.
² University of Birmingham Microbiome Treatment Centre and Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Department of Gastroenterology, Royal Wolverhampton NHS trust, Wolverhampton, UK; University of Wolverhampton, Wolverhampton, UK.

Comment

Jonathan P Segal et al. Lancet Gastroenterol Hepatol. 2020 Jul.

. 2020 Jul;5(7):639-640.

doi: 10.1016/S2468-1253(20)30153-9. Epub 2020 May 20.

¹ Department of Gastroenterology, St Mary's Hospital, London W2 1NY, UK. Electronic address: Jonathansegal1@nhs.net.
² University of Birmingham Microbiome Treatment Centre and Institute of Applied Health Research, University of Birmingham, Birmingham, UK; Department of Gastroenterology, Queen Elizabeth Hospital Birmingham, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK.
³ Department of Gastroenterology, Royal Wolverhampton NHS trust, Wolverhampton, UK; University of Wolverhampton, Wolverhampton, UK.

No abstract available

Comment in

Prevention of COVID-19 in patients with IBD - Authors' reply.
Ding NS, An P, Dong W, Ding Y. Ding NS, et al. Lancet Gastroenterol Hepatol. 2020 Jul;5(7):640-641. doi: 10.1016/S2468-1253(20)30156-4. Lancet Gastroenterol Hepatol. 2020. PMID: 32553142 Free PMC article. No abstract available.

Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China.
An P, Ji M, Ren H, Su J, Ding NS, Kang J, Yin A, Zhou Q, Shen L, Zhao L, Jiang X, Xiao Y, Tan W, Lv X, Li J, Liu S, Zhou J, Chen H, Xu Y, Liu J, Chen M, Cao J, Zhou Z, Shen L, Tan S, Yu H, Dong W, Ding Y. An P, et al. Lancet Gastroenterol Hepatol. 2020 Jun;5(6):525-527. doi: 10.1016/S2468-1253(20)30121-7. Epub 2020 Apr 17. Lancet Gastroenterol Hepatol. 2020. PMID: 32311321 Free PMC article. No abstract available.

1. An P, Ji M, Ren H. Prevention of COVID-19 in patients with inflammatory bowel disease in Wuhan, China. Lancet Gastroenterol Hepatol. 2020;5:525–527. - PMC - PubMed
1. British Society of Gastroenterology BSG COVID-19 Guidance on IBD patient risk groups. https://www.bsg.org.uk/covid-19-advice/bsg-advice-on-ibd-patient-risk-gr...
1. GBD 2017 Inflammatory Bowel Disease Collaborators The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Gastroenterol Hepatol. 2020;5:17–30. - PMC - PubMed
1. Kennedy NA, Jones G-R, Lamb CA. British Society of Gastroenterology guidance for management of inflammatory bowel disease during the COVID-19 pandemic. Gut. 2020 doi: 10.1136/gutjnl-2020-321244. published online April 17. - DOI - PMC - PubMed
1. Yang C, Singh P, Singh H. Systematic review: thalidomide and thalidomide analogues for treatment of inflammatory bowel disease. Aliment Pharmacol Ther. 2015;41:1079–1093. - PubMed